 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: HOE-901 | HOE901 | Lantus®
                                 insulin glargine is an approved drug (FDA and EMA (2000)) Compound class: 
                                                            Peptide
                                 
                                    
                                        Comment: Insulin glargine is a recombinant, modified analogue of human insulin. The chemical structure shown here was generated using the SMILES from PubChem CID 44146714. A number of insulin glargine biosimilars have been approved internationally since the expiration of patents on Lantus® in 2014: a comprehensive list that is maintained by the Generics and Biosimilar Initiative (https://www.gabionline.net) is available here. The first fully interchangeable biosimilar to be FDA approved was Semglee® (insulin glargine-yfgn; Mylan Pharmaceuticals), in July 2021.   View more information in the IUPHAR Pharmacology Education Project: glargine | 
 | |||||||||||||||